AAAAAA

   
Results: 1-12 |
Results: 12

Authors: HOLCOMBE JH ZALANI S HOEN H HARRIS C
Citation: Jh. Holcombe et al., COMPARISON OF INSULIN LISPRO AND REGULAR INSULIN IN CONTINUOUS INSULIN INFUSION-PUMP THERAPY, Diabetologia, 41, 1998, pp. 877-877

Authors: HOLCOMBE JH BRUNELLE R ZALANI S DEEB LC
Citation: Jh. Holcombe et al., COMPARATIVE-STUDY OF INSULIN LISPRO AND REGULAR INSULIN IN PREPUBERTAL CHILDREN WITH TYPE-I DIABETES, Diabetes, 47, 1998, pp. 375-375

Authors: KOTSANOS JG VIGNATI L HUSTER W ANDREJASICH C BOGGS MB JACOBSON AM MARRERO D MATHIAS SD PATRICK SD ZALANI S ANDERSON J
Citation: Jg. Kotsanos et al., HEALTH-RELATED QUALITY-OF-LIFE RESULTS FROM MULTINATIONAL CLINICAL-TRIALS OF INSULIN LISPRO - ASSESSING BENEFITS OF A NEW DIABETES THERAPY, Diabetes care, 20(6), 1997, pp. 948-958

Authors: ZALANI S COPPAGE A HOLLEYGUTHRIE E KENNEY S
Citation: S. Zalani et al., THE CELLULAR YY1 TRANSCRIPTION FACTOR BINDS A CIS-ACTING, NEGATIVELY REGULATING ELEMENT IN THE EPSTEIN-BARR-VIRUS BRLF1 PROMOTER, Journal of virology, 71(4), 1997, pp. 3268-3274

Authors: HOLCOMBE J ZALANI S ARORA V GILL A HEADLEE S
Citation: J. Holcombe et al., PATIENT PREFERENCE FOR INSULIN LISPRO VERSUS HUMULIN-R IN ADOLESCENTSWITH TYPE-I DIABETES, Diabetologia, 40, 1997, pp. 1350-1350

Authors: HOLCOMBE J ZALANI S ARORA V
Citation: J. Holcombe et al., COMPARATIVE-STUDY OF INSULIN LISPRO AND REGULAR INSULIN IN 481 ADOLESCENTS WITH TYPE-I DIABETES, Diabetologia, 40, 1997, pp. 1352-1352

Authors: GLAZER B ZALANI S SYMANOWSKI S UMINGER G ANDERSON J BASTYR E
Citation: B. Glazer et al., CARDIOVASCULAR SAFETY PROFILE OF INSULIN LISPRO (LP), Diabetologia, 40, 1997, pp. 1380-1380

Authors: HOLCOMBE J ZALANI S ARORA V HEADLEE S GILL A
Citation: J. Holcombe et al., INSULIN LISPRO (LP) RESULTS IN LESS NOCTURNAL HYPOGLYCEMIA COMPARED WITH REGULAR HUMAN INSULIN IN ADOLESCENTS WITH TYPE-I DIABETES, Diabetes, 46, 1997, pp. 402-402

Authors: HOLCOMBE J ZALANI S ARORA V HEADLEE S GILL A
Citation: J. Holcombe et al., COMPARATIVE-STUDY OF INSULIN LISPRO AND REGULAR INSULIN IN 481 ADOLESCENTS WITH TYPE-I DIABETES, Diabetes, 46, 1997, pp. 1253-1253

Authors: ZALANI S HOLLEYGUTHRIE E KENNEY S
Citation: S. Zalani et al., EPSTEIN-BARR VIRAL LATENCY IS DISRUPTED BY THE IMMEDIATE-EARLY BRLF1 PROTEIN THROUGH A CELL-SPECIFIC MECHANISM, Proceedings of the National Academy of Sciences of the United Statesof America, 93(17), 1996, pp. 9194-9199

Authors: ZHANG Q HONG Y DORSKY D HOLLEYGUTHRIE E ZALANI S ELSHIEKH NA KIEHL A LE T KENNEY S
Citation: Q. Zhang et al., FUNCTIONAL AND PHYSICAL INTERACTIONS BETWEEN THE EPSTEIN-BARR-VIRUS (EBV) PROTEINS BZLF1 AND BMRF1 - EFFECTS ON EBV TRANSCRIPTION AND LYTICREPLICATION, Journal of virology, 70(8), 1996, pp. 5131-5142

Authors: ZALANI S HOLLEYGUTHRIE E KENNEY S
Citation: S. Zalani et al., THE ZIF268 CELLULAR TRANSCRIPTION FACTOR ACTIVATES EXPRESSION OF THE EPSTEIN-BARR-VIRUS IMMEDIATE-EARLY BRLF1 PROMOTER, Journal of virology, 69(6), 1995, pp. 3816-3823
Risultati: 1-12 |